Results 161 to 170 of about 150,527 (224)

Clinical factors and practical strategies to optimize amikacin liposome inhalation suspension therapy in refractory Mycobacterium avium complex pulmonary disease. [PDF]

BMC Pulm Med
Kurosaki F, Takigami A, Kurosaki A, Hisata S, Nakayama M, Mato N, Maemondo M.   +6 more
europepmc   +1 more source

Fatal systemic AA amyloidosis with pulmonary <i>Mycobacterium avium</i> infection: an autopsy case report. [PDF]

ASM Case Rep
Takahashi Y, Hanada S, Uruga H, Tsujimoto T, Tsuboi E, Nakahama H, Nei Y, Mitsumura T, Miyamoto A, Tamaoka M.   +9 more
europepmc   +1 more source

Immunopathological outcomes are isolate dependent in chronic Mycobacterium avium complex pulmonary disease. [PDF]

Dis Model Mech
Shaw TD, Lam H, Dutt TS, Pearce CM, Alshiraihi I, Obregon-Henao A, Henao-Tamayo M, Maloney Norcross SE, Meibohm B, Jackson M, Gonzalez-Juarrero M.   +10 more
europepmc   +1 more source

Diagnostic Discordance During MDR-TB Treatment: Retrospective Identification of <i>Mycobacterium avium Complex</i>-Associated Nontuberculous Mycobacterium by Whole-Genome Sequencing. [PDF]

Microorganisms
Rukasha I, Kaapu KG, Nemaguvhuni NF, Wells-Hunter F, Sharma A, Phelan JE, Kolobe MJ, Lekalakala-Mokaba MR, Warren RM, Costa Conceição E.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mycobacterium avium: an overview

Tuberculosis, 2019
Mycobacterium avium is an environmental microorganism found in soil and water sources worldwide. It is the most prevalent species of nontuberculous mycobacteria that causes infectious diseases, especially in immunocompromised individuals. This review discusses and highlights key topics about M.
Caroline Busatto, Júlia Silveira Vianna, Lande Vieira da Silva, Ivy Bastos Ramis, Pedro Eduardo Almeida da Silva   +4 more
openaire   +2 more sources

MYCOBACTERIUM-AVIUM COMPLEX

Infectious Disease Clinics of North America, 1994
The ubiquitous MAC causes disseminated disease in a large proportion of patients with AIDS. It will become an increasingly important clinical pathogen as more patients survive within the context of prolonged immunodeficiency. The primary risk factor for DMAC is CD4 < 100 mm3 and thus the institution of adequate prophylaxis will significantly reduce its
D S, Rubin, J J, Rahal
openaire   +2 more sources

Waterborne Mycobacterium avium Infection

JAMA: The Journal of the American Medical Association, 1989
To the Editor. — In a recently published article, du Moulin et al 1 studied hospital tap water for the presence of mycobacteria. Mycobacterium avium , a frequent opportunistic pathogen among patients with the acquired immunodeficiency syndrome (AIDS), was isolated from 41% of the sites investigated.
P, Yagupsky, M A, Menegus
openaire   +2 more sources

Mycobacterium Avium Intracellulare

Journal of Spinal Disorders, 1998
A case of vertebral osteomyelitis secondary to Mycobacterium avium intracellulare mimicking Pott's paraplegia is reviewed. To our knowledge, it represents the first published case in a patient without gross immunocompromise. The importance of early differentiation from tuberculous osteomyelitis is stressed as treatment regimens differ and outcomes may ...
Weiner, Bradley K., Love, Tim W., Fraser, Robert D.   +2 more
openaire   +2 more sources

Osteomyelitis Caused by Mycobacterium Avium

Acta Orthopaedica Scandinavica, 1983
Osteomyelitis due to M. avium is extremely rare and frequently fatal. The successful cure of an 11-year-old patient with multiple mycobacterial lesions in the pelvis and right humerus is reported. Although the mycobacteria were in vitro resistant to most antituberculous drugs a five-drug regimen was given over a total of 2 1/2 years.
S, Collert, B, Petrini, K, Wickman
openaire   +2 more sources